SITC was successfully selected into the Standard & Poor's 2025 Sustainability Yearbook and was awarded the "Industry Mover" award. The company's continued efforts in environmental, social and governance (ESG) in 2023-2024 have achieved remar… ...
Cytovia Therapeutics, Inc. announced new preclinical data for its TALEN® gene-edited, iPSC-derived NK cells and GPC3-targeted Flex-NK™ bispecific antibodies.
” said Swethajit Biswas, M.D., Ph.D., Chief Medical Officer at CDR-Life. “We look forward to the continued progress of our innovative CDR404 T-cell engager program as we near the initiation
LARKSPUR, Calif., September 27, 2023 – Aulos Bioscience, an immuno-oncology company working to revolutionize cancer care through the development of potentially best-in-class IL-2 therapeutics, today announced t...
LUND, SE / ACCESSWIRE / November 3, 2023 /BioInvent International (STO:BINV): Preliminary data from Phase 1 part show encouraging early efficacy signals Robust partial response in one patient with gastrointestinal tumor; 7 cases of stable disease ...
In addition, the Company donated RMB2 million to Shanghai Maritime University for educational program expenses. 36 SITC International Holdings Company Limited Harmonious Development Case: Seminar Co-hosted by SITC and Shanghai Maritime University SITC and the College of Information Engineering of Shang...